Lincoln Pharmaceuticals Ltd.

BSE: 531633 | NSE: LINCOLN |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE405C01035 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Lincoln Pharma Lincoln Pharmaceuticals Ltd. | BSE 530.65 -3.15 (-0.59%) | NSE 529.00 -3.40 (-0.64%) | Trade | Add

BSE Live

Oct 31, 13:47

530.65 -3.15 (-0.59%)

Volume

AVERAGE VOLUME

5-Day

903

10-Day

981

30-Day

1,867

301

Prev. Close

533.80
Open Price

531.80

Bid Price (Qty.)
528.05 (52)
Offer Price (Qty.)
531.10 (28)

NSE Live

Oct 31, 13:47

529.00 -3.40 (-0.64%)

Volume

AVERAGE VOLUME

5-Day

16,268

10-Day

14,398

30-Day

17,648

4,497

Prev. Close

532.40
Open Price

532.00

Bid Price (Qty.)
529.05 (1)
Offer Price (Qty.)
529.90 (1)

Financials

Print/Copy to Excel : Go

Key Financial Ratios of Lincoln Pharmaceuticals (in Rs. Cr.)	Mar 25	Mar 24	Mar 23	Mar 22	Mar 21
Per Share Ratios
Basic EPS (Rs.)	41.11	46.58	36.40	34.63	31.11
Diluted EPS (Rs.)	41.11	46.58	36.40	34.63	31.11
Cash EPS (Rs.)	47.55	51.89	40.97	38.66	34.91
Book Value [ExclRevalReserve]/Share (Rs.)	335.34	295.98	250.86	216.12	187.85
Book Value [InclRevalReserve]/Share (Rs.)	335.34	295.98	250.86	216.12	187.85
Revenue from Operations/Share (Rs.)	311.15	289.84	254.78	235.71	212.09
PBDIT/Share (Rs.)	61.89	67.07	55.76	52.66	46.42
PBIT/Share (Rs.)	55.45	61.76	51.18	48.62	42.64
PBT/Share (Rs.)	54.51	61.03	50.17	47.90	41.86
Net Profit/Share (Rs.)	41.11	46.58	36.40	34.63	31.12
NP After MI And SOA / Share (Rs.)	41.11	46.58	36.40	34.63	31.11
Profitability Ratios
PBDIT Margin (%)	19.89	23.13	21.88	22.34	21.88
PBIT Margin (%)	17.82	21.30	20.08	20.62	20.10
PBT Margin (%)	17.51	21.05	19.68	20.32	19.73
Net Profit Margin (%)	13.21	16.07	14.28	14.69	14.67
NP After MI And SOA Margin (%)	13.21	16.07	14.28	14.69	14.66
Return on Networth/Equity (%)	12.25	15.73	14.50	16.02	16.58
Return on Capital Employed (%)	16.07	20.34	19.89	21.94	22.10
Return on Assets (%)	10.33	13.32	12.41	12.97	13.54
Total Debt/Equity (X)	0.00	0.00	0.00	0.00	0.00
Asset Turnover Ratio (%)	0.83	0.90	0.91	0.95	92.34
Liquidity Ratios
Current Ratio (X)	4.71	4.84	5.08	3.90	4.17
Quick Ratio (X)	3.97	4.01	4.11	3.10	3.53
Inventory Turnover Ratio (X)	2.75	2.73	2.48	2.66	9.10
Dividend Payout Ratio (NP) (%)	0.00	3.22	4.12	4.32	0.00
Dividend Payout Ratio (CP) (%)	0.00	2.89	3.66	3.87	0.00
Earnings Retention Ratio (%)	0.00	96.78	95.88	95.68	0.00
Cash Earnings Retention Ratio (%)	0.00	97.11	96.34	96.13	0.00
Coverage Ratios
Interest Coverage Ratios (%)	65.84	91.70	55.01	72.68	54.60
Interest Coverage Ratios (Post Tax) (%)	65.84	91.70	55.01	72.68	54.60
Valuation Ratios
Enterprise Value (Cr.)	1,082.31	1,159.77	646.08	574.49	436.11
EV/Net Operating Revenue (X)	1.74	2.00	1.27	1.22	1.03
EV/EBITDA (X)	8.73	8.63	5.79	5.45	4.70
MarketCap/Net Operating Revenue (X)	1.77	2.02	1.33	1.32	1.06
Retention Ratios (%)	0.00	96.77	95.87	95.67	0.00
Price/BV (X)	1.64	1.98	1.35	1.44	1.20
Price/Net Operating Revenue	1.77	2.02	1.33	1.32	1.06
Earnings Yield	0.07	0.08	0.11	0.11	0.14